Literature DB >> 6818832

Characterization and properties of the human and bovine lactotransferrins extracted from the faeces of newborn infants.

G Spik, B Brunet, C Mazurier-Dehaine, G Fontaine, J Montreuil.   

Abstract

Human lactotransferrin was characterized in the faecal extracts from breastfed babies. Quantitative determination of human copro-lactotransferrin from birth for a period of up to 3 weeks showed that the daily elimination decreased from 35 to 5 mg. The amount of copro-lactotransferrin corresponding to the endogenous secretion was calculated to be from 0.5 to 1 mg per day. When a cow's milk diet supplemented by partially or completely iron-saturated human or bovine lactotransferrin was fed to the babies, the amounts of copro-lactotransferrin excreted depended on the origin and on the iron saturation of the lactoransferrin. In particular, the amount of bovine copro-lactotransferrin in the faeces averaged 200 mg per day. The human and bovine copro-lactotransferrins were isolated by ion-exchange chromatography or by affinity chromatography and were still able to bind iron. The fingerprints of native human and bovine lactotransferrins hydrolysed in vitro by infant's gastric or duodenal secretions showed that both proteins were not extensively digested. This demonstrates that these lactotransferrins ingested by babies are not completely destroyed and keep their ability to bind iron, and thus may supplement the bacteriostatic effects of the endogenous lactotransferrin in the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818832     DOI: 10.1111/j.1651-2227.1982.tb09560.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  15 in total

1.  Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms.

Authors:  W L Hu; J Mazurier; G Sawatzki; J Montreuil; G Spik
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

Review 2.  Biological role of lactoferrin.

Authors:  L Sánchez; M Calvo; J H Brock
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

3.  Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections.

Authors:  B Fornarini; S Iacobelli; N Tinari; C Natoli; M De Martino; G Sabatino
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation.

Authors:  T W Hutchens; J F Henry; T T Yip
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  The survival of ingested lactoferrin in the gastrointestinal tract of adult mice.

Authors:  H Kuwata; T T Yip; K Yamauchi; S Teraguchi; H Hayasawa; M Tomita; T W Hutchens
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Antibacterial prophylaxis with lactoferrin in neutropenic patients.

Authors:  U Trümpler; P W Straub; A Rosenmund
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

7.  Biochemistry of human milk in early lactation.

Authors:  G Harzer; M Haug; J G Bindels
Journal:  Z Ernahrungswiss       Date:  1986-06

8.  Effect of intracellular iron depletion by picolinic acid on expression of the lactoferrin receptor in the human colon carcinoma cell subclone HT29-18-C1.

Authors:  T Mikogami; T Marianne; G Spik
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

9.  Neolactoferrin as a stimulator of innate and adaptive immunity.

Authors:  A D Chernousov; M F Nikonova; N I Sharova; A N Mitin; M M Litvina; P E Sadchikov; I L Goldman; A A Yarilin; E R Sadchikova
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

10.  Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding.

Authors:  Sandrine Moussa; Mohammad-Ali Jenabian; Jean Chrysostome Gody; Josiane Léal; Gérard Grésenguet; Alain Le Faou; Laurent Bélec
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.